Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/6495
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMusaeva Nargiza Bakhtiyorovna-
dc.date.accessioned2023-03-01T10:39:48Z-
dc.date.available2023-03-01T10:39:48Z-
dc.date.issued2023-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/6495-
dc.description.abstractA study was made of the features of hemostatic disorders in patients with rheumatoid arthritis, depending on the activity and duration of the pathological process. It has been shown that changes in the hemostasis system with a tendency to hypercoagulability and thrombosis are formed in patients with rheumatoid arthritis against the background of inflammation, depending on the activity of the pathological process and the duration of the disease. Persons with the debut of rheumatoid arthritis, not exceeding 18 months from the onset of the first clinical manifestations, in the absence of disease-modifying therapy, have laboratory manifestations corresponding to the activation of the hemocoagulation cascade. Inflammation in active articular syndrome at the onset is characterized by an increase in the adhesive properties of platelets, hypercoagulability, thrombinemia, and a decrease in the reserves of the fibrinolytic system. The most important prognostic laboratory sign associated with the severity of inflammation in rheumatoid arthritis is thrombinemiaen_US
dc.language.isoen_USen_US
dc.publisherAsian journal of Pharmaceutical and biological researchen_US
dc.subjectrheumatoid arthritis, disease activity, disease duration, hemostasis.en_US
dc.titleСoagulation hemostasis disorders in rheumatoid arthritisen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
1-9.pdfСoagulation hemostasis disorders in rheumatoid arthritis296.06 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.